Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.
BACKGROUND: The 7-valent pneumococcal conjugate (PCV7) vaccine's impact on invasive pneumococcal disease (IPD) is well described, but few reports exist on the additional impact of the 13-valent vaccine (PCV13). METHODS: We calculated the IPD incidence across all ages in a surveillance project f...
Main Authors: | Moore, C, Paul, J, Foster, D, Mahar, SA, Griffiths, D, Knox, K, Peto, T, Walker, A, Crook, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England.
by: Foster, D, et al.
Published: (2011) -
Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
by: Foster, D, et al.
Published: (2008) -
Impact of 13-valent pneumococcal conjugate vaccine on colonisation and invasive disease in Cambodian children
by: Turner, P, et al.
Published: (2019) -
Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children
by: Ayieko, P, et al.
Published: (2013) -
The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.
by: Trück, J, et al.
Published: (2016)